{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:16:36Z","timestamp":1784027796504,"version":"3.55.0"},"reference-count":116,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":2606,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:00:00Z","timestamp":1545264000000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In an aging population, the number of patients affected by heart failure and cancer is constantly increasing and together these two conditions account for more than 50% of all deaths worldwide. Both diseases share similar risk factors including smoking, obesity, and hypertension. Presenting symptoms may also be similar, with patients frequently complaining of dyspnea, fatigue, and anorexia. Many affected patients, especially those with more advanced heart failure or cancer, suffer also from metabolic disorders. These can lead eventually to muscle wasting, sarcopenia, and cachexia. These complications are associated with increased morbidity, a poorer quality of life, a worse prognosis and indeed they represent an independent risk factor for the advancement of the underlying disease itself. Very few therapeutic options have been established to treat these co-morbidities. For sarcopenia the only validated treatment is resistance training. Moreover, there is currently no guideline recommended therapy for the treatment of cachexia. New treatment strategies are urgently needed to prevent and treat muscle and wasting disorders in patients with chronic diseases such as cancer and chronic heart failure.<\/jats:p>","DOI":"10.1002\/ehf2.12389","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T06:28:52Z","timestamp":1545287332000},"page":"1092-1098","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Metabolic Disorders in Heart Failure and Cancer"],"prefix":"10.1093","volume":"5","author":[{"given":"Alessia","family":"Lena","sequence":"first","affiliation":[{"name":"Division of Cardiology and Metabolism, Department of Cardiology, Charit\u00e9 , Berlin ,","place":["Germany"]},{"name":"Berlin-Brandenburg Center for Regenerative Therapies (BCRT) , Berlin ,","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), partner site , Berlin ,","place":["Germany"]},{"name":"Department of Cardiology, Charit\u00e9 Campus Benjamin Franklin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.S.","family":"Coats","sequence":"additional","affiliation":[{"name":"IRCCS, San Raffaele, Pisana , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus S.","family":"Anker","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Metabolism, Department of Cardiology, Charit\u00e9 , Berlin ,","place":["Germany"]},{"name":"Berlin-Brandenburg Center for Regenerative Therapies (BCRT) , Berlin ,","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research), partner site , Berlin ,","place":["Germany"]},{"name":"Department of Cardiology, Charit\u00e9 Campus Benjamin Franklin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,20]]},"reference":[{"key":"2026012115105723200_ehf212389-bib-0001","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"2026012115105723200_ehf212389-bib-0002","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"2026012115105723200_ehf212389-bib-0003","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","article-title":"Economic burden of cancer across the European Union: a population-based cost analysis","volume":"14","author":"Luengo-Fernandez","year":"2013","journal-title":"Lancet Oncol"},{"key":"2026012115105723200_ehf212389-bib-0004","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00019053-200826060-00001","article-title":"Economic burden of heart failure in the elderly","volume":"26","author":"Liao","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"2026012115105723200_ehf212389-bib-0005","first-page":"ii13","volume-title":"What are the costs of heart failure?","author":"Braunschweig","year":"2011"},{"key":"2026012115105723200_ehf212389-bib-0006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ehf2.12125","article-title":"Palliative care in heart failure: facts and numbers","volume":"4","author":"Riley","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0007","first-page":"175","article-title":"The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients","volume":"8","author":"Walsh","year":"2000","journal-title":"Support Care Cancer"},{"key":"2026012115105723200_ehf212389-bib-0008","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ehf2.12237","article-title":"Muscle wasting and sarcopenia in heart failure and beyond: update 2017","volume":"4","author":"Springer","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0009","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ehf2.12209","article-title":"Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)","volume":"4","author":"Saitoh","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0010","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/ejhf.1098","article-title":"Co-morbidities in heart failure beginning to sprout-and no end in sight?","volume":"19","author":"Haehling","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0011","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared Risk Factors in Cardiovascular Disease and Cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"2026012115105723200_ehf212389-bib-0012","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"Authors\/Task Force Members; ESC Committee for Practice Guidelines (CPG); Document Reviewers. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"19","author":"Zamorano","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0014","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/jcsm.12229","article-title":"Is cardiac wasting accompanied by skeletal muscle loss in breast cancer patients receiving anticancer treatment?","volume":"8","author":"Ishida","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0015","doi-asserted-by":"crossref","first-page":"10436","DOI":"10.1073\/pnas.1601650113","article-title":"Oncometabolite d-2-hydroxyglutarate impairs \u03b1-ketoglutarate dehydrogenase and contractile function in rodent heart","volume":"113","author":"Karlstaedt","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026012115105723200_ehf212389-bib-0016","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/ejhf.670","article-title":"Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study","volume":"18","author":"Anker","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0017","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ehf2.12184","article-title":"Cardiac muscle wasting in individuals with cancer cachexia","volume":"4","author":"Barkhudaryan","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0018","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ehf2.12153","article-title":"Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance","volume":"4","author":"Cohen-Solal","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0019","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ehf2.12176","article-title":"Associations between acylcarnitine to free carnitine ratio and adverse prognosis in heart failure patients with reduced or preserved ejection fraction","volume":"4","author":"Yoshihisa","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0020","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ejhf.1049","article-title":"Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience","volume":"20","author":"Fornaro","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0021","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ejhf.472","article-title":"Incidence of cancer in patients with chronic heart failure: a long-term follow-up study","volume":"18","author":"Banke","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0022","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jacc.2018.01.069","article-title":"Lack of Association Between Heart Failure and Incident Cancer","volume":"71","author":"Selvaraj","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026012115105723200_ehf212389-bib-0023","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ehf2.12091","article-title":"Red cell distribution width and mortality in acute heart failure patients with preserved and reduced ejection fraction","volume":"3","author":"Sotiropoulos","year":"2016","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0024","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ehf2.12130","article-title":"Immunosuppressive treatment in fulminant myocarditis and gene expression pattern associated with, but no histological confirmation of giant cell myocarditis","volume":"4","author":"Fruhwald","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0025","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jcsm.12212","article-title":"Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis","volume":"8","author":"Nishikawa","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0026","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ehf2.12105","article-title":"Parenica J; AHEAD registry investigators. Worse prognosis of real-world patients with acute heart failure from the Czech AHEAD registry in comparison to patients from the RELAX-AHF trial","volume":"4","author":"Spinar","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0027","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/jcsm.12220","article-title":"Blum D, Wilcock A, Fayers P, Strasser F, Baracos VE, Hjermstad MJ, Kaasa S, Laird B, Solheim TS; European Palliative Care Cancer Symptom study group. The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis","volume":"8","author":"Vagnildhaug","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0028","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jcsm.12213","article-title":"Development of a bedside viable ultrasound protocol to quantify appendicular lean tissue mass","volume":"8","author":"Paris","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0029","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/jcsm.12177","article-title":"Musculoskeletal decline and mortality: prospective data from the Geelong Osteoporosis Study","volume":"8","author":"Pasco","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0030","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/jcsm.12224","article-title":"The incidence of sarcopenia among hospitalized older patients: results from the Glisten study","volume":"8","author":"Martone","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0031","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ehf2.12162","article-title":"Protocol update and preliminary results of EACVI\/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology. ESC Cardiac Oncology Toxicity Long-Term Registry Investigators","volume":"4","author":"Lancellotti","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0032","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ehf2.12168","article-title":"Data privacy management and data quality monitoring in the German Centre for Cardiovascular Research's multicentre TranslatiOnal Registry for CardiomyopatHies (DZHK-TORCH)","volume":"4","author":"Schwaneberg","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0033","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ejhf.991","article-title":"Filippatos G; ESC Heart Failure Long-Term Registry Investigators. Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry","volume":"20","author":"Mebazaa","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0034","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/ejhf.879","article-title":"Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction","volume":"19","author":"Rastogi","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ehf2.12145","article-title":"TranslatiOnal Registry for CardiomyopatHies (TORCH) - rationale and first results","volume":"4","author":"Seyler","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0036","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ehf2.12124","article-title":"Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project","volume":"4","author":"Pose","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0037","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/jcsm.12205","article-title":"Effect of bimagrumab on thigh muscle volume and composition in men with casting-induced atrophy","volume":"8","author":"Rooks","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0038","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jcsm.12209","article-title":"Circulating Activin A predicts survival in cancer patients","volume":"8","author":"Loumaye","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0039","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/jcsm.12199","article-title":"Muscle mass as a target to reduce fatigue in patients with advanced cancer","volume":"8","author":"Neefjes","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0040","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/CIRCULATIONAHA.105.583666","article-title":"Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options","volume":"113","author":"Tang","year":"2006","journal-title":"Circulation"},{"key":"2026012115105723200_ehf212389-bib-0041","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ejhf.514","article-title":"Systematic review and meta-analysis of iron therapy in anaemic adults without chronic kidney disease: updated and abridged Cochrane review","volume":"18","author":"Clevenger","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0042","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ehf2.12179","article-title":"Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany","volume":"4","author":"Theidel","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0043","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ehf2.12101","article-title":"Left ventricular ejection fraction recovery in patients with heart failure treated with intravenous iron: a pilot study","volume":"3","author":"N\u00fa\u00f1ez","year":"2016","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0044","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ehf2.12190","article-title":"Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure","volume":"4","author":"Ikeda","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0045","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ejhf.746","article-title":"Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure","volume":"19","author":"Sokolski","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0046","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ejhf.647","article-title":"Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative","volume":"19","author":"Coiro","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0047","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ejhf.519","article-title":"Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009","volume":"18","author":"Staszewsky","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0048","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ehf2.12086","article-title":"Development and validation of a novel non-contact monitor of nocturnal respiration for identifying sleep-disordered breathing in patients with heart failure","volume":"3","author":"Savage","year":"2016","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0049","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ehf2.12193","article-title":"Sleep-disordered breathing in heart failure: facts and numbers","volume":"4","author":"Pietrock","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0050","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/ejhf.681","article-title":"The Model for End-stage Liver Disease score in acute heart failure: hepatorenal dysfunction hides behind","volume":"18","author":"Parissis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0051","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ehf2.12123","article-title":"Dynamic changes of serum microRNA-122-5p through therapeutic courses indicates amelioration of acute liver injury accompanied by acute cardiac decompensation","volume":"4","author":"Koyama","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0052","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ehf2.12108","article-title":"Sexual function of patients with heart failure: facts and numbers","volume":"4","author":"Jaarsma","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0053","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ehf2.12182","article-title":"Sexual function of patients with heart failure: distinct phenotypes, distinct sexual function?","volume":"4","author":"Koutsampasopoulos","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0054","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ehf2.12209","article-title":"Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure","volume":"4","author":"Saitoh","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0055","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/jcsm.12192","article-title":"Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia","volume":"8","author":"Morley","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0056","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jcsm.12167","article-title":"Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016","volume":"7","author":"Haehling","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0057","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/jcsm.12191","article-title":"Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial","volume":"8","author":"Clark","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0058","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jcsm.12086","article-title":"Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure","volume":"7","author":"Sente","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0059","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/jcsm.12254","article-title":"Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure","volume":"8","author":"Barazzoni","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ehf2.12103","article-title":"Heart failure epidemiology and novel treatments in Japan: facts and numbers","volume":"3","author":"Konishi","year":"2016","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0061","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jcsm.12117","article-title":"Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact","volume":"7","author":"Konishi","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0062","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jcsm.12167","article-title":"Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016","volume":"7","author":"von Haehling","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0063","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","article-title":"Prevalence, incidence and clinical impact of cachexia: Facts and numbers\u2014Update 2014","volume":"5","author":"Haeling","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0064","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12020-012-9836-3","article-title":"Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status","volume":"43","author":"Christensen","year":"2013","journal-title":"Endocrine"},{"key":"2026012115105723200_ehf212389-bib-0065","first-page":"74","article-title":"Cardiac Cachexia: Perspectives for Prevention and Treatment","volume":"108","author":"Okoshi","year":"2017","journal-title":"Arq Bras Cardiol"},{"key":"2026012115105723200_ehf212389-bib-0066","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2026012115105723200_ehf212389-bib-0067","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"2026012115105723200_ehf212389-bib-0068","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","article-title":"Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure","volume":"34","author":"Fulster","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012115105723200_ehf212389-bib-0069","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","article-title":"Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review","volume":"57","author":"Shachar","year":"2016","journal-title":"Eur J Cancer"},{"key":"2026012115105723200_ehf212389-bib-0070","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jcsm.12147","article-title":"Welcome to the ICD-10 code for sarcopenia","volume":"7","author":"Anker","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0071","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/jcsm.12224","article-title":"The incidence of sarcopenia among hospitalized older patients: results from the Glisten study","volume":"8","author":"Martone","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0072","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/jcsm.12192","article-title":"Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia","volume":"8","author":"Morley","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0073","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jcsm.12049","article-title":"Prevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: results of the COMO VAI? study","volume":"7","author":"Barbosa-Silva","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0074","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","article-title":"Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure","volume":"34","author":"Fulster","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012115105723200_ehf212389-bib-0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13539-010-0014-2","article-title":"An overview of sarcopenia: facts and numbers on prevalence and clinical impact","volume":"1","author":"von Haehling","year":"2010","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0076","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jcsm.12157","article-title":"Prevalence and incidence of sarcopenia in the very old: findings from the Newcastle 85+ Study","volume":"8","author":"Dodds","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0077","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jcsm.12193","article-title":"Muscle wasting in young patients with dilated cardiomyopathy","volume":"8","author":"Hajahmadi","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0078","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jcsm.12163","article-title":"Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study","volume":"8","author":"Yang","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0079","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jcsm.12057","article-title":"Muscle RING-finger 2 and 3 maintain striated-muscle structure and function","volume":"7","author":"Lodka","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0080","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/jcsm.12204","article-title":"Cardiac troponin T and fast skeletal muscle denervation in ageing","volume":"8","author":"Xu","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0081","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jcsm.12096","article-title":"Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo","volume":"7","author":"Patel","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0082","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jcsm.12086","article-title":"Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure","volume":"7","author":"Sente","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0083","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jcsm.12032","article-title":"Conversion of leucine to \u03b2-hydroxy-\u03b2-methylbutyrate by \u03b1-keto isocaproate dioxygenase is required for a potent stimulation of protein synthesis in L6 rat myotubes","volume":"7","author":"Gir\u00f3n","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0084","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/jcsm.12078","article-title":"Increased expression of H19\/miR-675 is associated with a low fat-free mass index in patients with COPD","volume":"7","author":"Lewis","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jcsm.12048","article-title":"SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes","volume":"7","author":"Malmstrom","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0086","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jcsm.12076","article-title":"Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study","volume":"7","author":"Tyrovolas","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0087","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jcsm.12221","article-title":"Psoas as a sentinel muscle for sarcopenia: a flawed premise","volume":"8","author":"Baracos","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0088","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcsm.12159","article-title":"Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating?","volume":"8","author":"Gonzalez","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0089","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jcsm.12130","article-title":"Sarcopenia among patients receiving hemodialysis: weighing the evidence","volume":"8","author":"Kittiskulnam","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0090","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/jcsm.12180","article-title":"Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer","volume":"8","author":"Rutten","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0091","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jcsm.12149","article-title":"Validation of the SarQoL\u00ae, a specific health-related quality of life questionnaire for Sarcopenia","volume":"8","author":"Beaudart","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0092","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3945\/an.115.008367","article-title":"Nutritional Supplements in Support of Resistance Exercise to Counter Age-Related Sarcopenia","volume":"6","author":"Phillips","year":"2015","journal-title":"Adv Nutr"},{"key":"2026012115105723200_ehf212389-bib-0093","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ehf2.12237","article-title":"Muscle wasting and sarcopenia in heart failure and beyond: update 2017","volume":"4","author":"Springer","year":"2017","journal-title":"ESC Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0094","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jcsm.12217","article-title":"Highlights from the 9th Cachexia Conference","volume":"8","author":"Ebner","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0095","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jcsm.12118","article-title":"Cardiac cachexia: hic et nunc","volume":"7","author":"Loncar","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0096","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-5273(02)00233-4","article-title":"The syndrome of cardiac cachexia","volume":"85","author":"Anker","year":"2002","journal-title":"Int J Cardiol"},{"key":"2026012115105723200_ehf212389-bib-0097","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/jcsm.12256","article-title":"Casting the net broader to confirm our imaginations: the long road to treating wasting disorders","volume":"8","author":"Haehling","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0098","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"2026012115105723200_ehf212389-bib-0099","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cardiores.2006.08.018","article-title":"Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure","volume":"73","author":"von Haehling","year":"2007","journal-title":"Cardiovasc Res"},{"key":"2026012115105723200_ehf212389-bib-0100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijcard.2009.07.042","article-title":"Nutritional markers and prognosis in cardiac cachexia","volume":"146","author":"Ara\u00fajo","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026012115105723200_ehf212389-bib-0101","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","article-title":"Muscle wasting and cachexia in heart failure: mechanisms and therapies","volume":"14","author":"Haehling","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2026012115105723200_ehf212389-bib-0102","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02696650","article-title":"Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches","volume":"2","author":"Akashi","year":"2005","journal-title":"Curr Heart Fail Rep"},{"key":"2026012115105723200_ehf212389-bib-0103","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/jcsm.12191","article-title":"Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial","volume":"8","author":"Clark","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jcsm.12110","article-title":"The times they are a-changin\u2019: the Cachexia Conference goes annual","volume":"7","author":"Haehling","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jcsm.12106","article-title":"Unlocking the wasting enigma: Highlights from the 8th Cachexia Conference","volume":"7","author":"Ebner","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0106","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/jcsm.12247","article-title":"Oodles of opportunities: the Journal of Cachexia, Sarcopenia and Muscle in 2017","volume":"8","author":"von Haehling","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0107","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jcsm.12067","article-title":"Cancer cachexia causes skeletal muscle damage via transient receptor potential vanilloid 2-independent mechanisms, unlike muscular dystrophy","volume":"7","author":"Iwata","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0108","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jcsm.12171","article-title":"Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1","volume":"8","author":"McDonald","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0109","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/jcsm.12235","article-title":"Differentially expressed alternatively spliced genes in skeletal muscle from cancer patients with cachexia","volume":"9","author":"Narasimhan","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jcsm.12100","article-title":"Nutritional leucine supplementation attenuates cardiac failure in tumour-bearing cachectic animals","volume":"7","author":"Toneto","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0111","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jcsm.12116","article-title":"Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation","volume":"7","author":"Musolino","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0112","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/jcsm.12233","article-title":"Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia","volume":"8","author":"Bowen","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0113","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcsm.12127","article-title":"A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project","volume":"8","author":"Mochamat","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0114","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/ejhf.921","article-title":"The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology","volume":"19","author":"van Bilsen","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115105723200_ehf212389-bib-0115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jcsm.12126","article-title":"For and on behalf of the ACT-ONE study group. Espindolol for the treatment and prevention of cachexia in patients with stage III\/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)","volume":"7","author":"Stewart Coats","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026012115105723200_ehf212389-bib-0116","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jcsm.12136","article-title":"ACT-ONE - ACTION at last on cancer cachexia by adapting a novel action beta-blocker","volume":"7","author":"Lainscak","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12389","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/5\/6\/1092\/66137298\/eschf_5_6_1092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/5\/6\/1092\/66137298\/eschf_5_6_1092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:14:23Z","timestamp":1769026463000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/5\/6\/1092\/8403687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":116,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,12,20]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12389","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,12,1]]},"assertion":[{"value":"2018-11-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}